UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
Molecular markers of breast cancer metastasis
Weigelt, B.
Publication date
2005
Link to publication
Citation for published version (APA):
Weigelt, B. (2005). Molecular markers of breast cancer metastasis.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)
and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open
content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please
let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material
inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter
to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You
will be contacted as soon as possible.
Molecular Markers of Breast Cancer Metastasis
ACADEMISCH PROEFSCHRIFT
ter verkrijging van de graad van doctor aan de Universiteit van Amsterdam op gezag van de Rector Magnificus
Prof. Mr. P.F. van der Heijden
ten overstaan van een door het college voor promoties ingestelde commissie, in het openbaar te verdedigen in de Aula der Universiteit
op vrijdag 9 september 2005, te 10.00 uur
door
Britta Weigelt
Co-promotor:
Overige leden:
Dr. LJ. van 't Veer
Prof. Dr. A.J.M. Berns Prof. Dr. C.J. Cornelisse
Prof. Dr. DJ. Richel
Prof. Dr. R.A.E.M. Tollenaar Prof. Dr. R. Versteeg
Faculteit der Geneeskunde
Cover: René Magritte, Paysage, 1927.
Printed by Ponsen & Looijen bv, Wageningen. ISBN 90-6464-790-9
The research described in this thesis was financially supported by the Dutch Cancer Society (NKB/KWF) and the Netherlands Genomics Initiative. For the publication of this thesis financial support by the Dutch Cancer Society, the Netherlands Cancer Institute and GlaxoSmithKline is gratefully acknowledged.
There's nothing new under the sun, but there are lots of old things we don't know.
